Needham & Company LLC Reiterates “Hold” Rating for Revance Therapeutics (NASDAQ:RVNC)
Needham & Company LLC reiterated their hold rating on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Friday morning,Benzinga reports. A number of other brokerages have also weighed in on RVNC. StockNews.com assumed coverage on Revance Therapeutics in a report on Monday, January 13th. They issued a “hold” […]
More Stories
Why Some Doctors Are Turning Against Vaccine Mandates
By Zachary Stieber For Dr. Anish Koka, vaccine mandates made sense. He has a daughter who received an organ transplant,...
Wall Street Review: Stocks End Week Mixed Amid Bulls-Bears Tug of War
By Panos Mourdoukoutas Equities finished the week mixed as a renewed tug-of-war played out between bullish investors focused on the...
Voting Under Fire: Zelenskyy Weighs Elections in Ukraine, but Wartime Obstacles Remain
By Chris Summers Ukrainian President Volodymyr Zelenskyy said on Dec. 9 he was prepared to hold elections within three months...
Suspect in Taiwan’s Deadly Knife Attack Acted Alone, Police Say
By T.J. Muscaro The man suspected of killing at least three people with a knife and discharging smokebombs in Taipei,...
Trump Reveals 50 State Tour to Celebrate America’s 250th Birthday
By Jacki Thrapp President Donald Trump has announced the U.S. 250 Freedom Tour to celebrate America’s 250th birthday. The tour,...
DOJ Seeking Appeals on Dismissals of Criminal Cases Against James Comey, Letitia James
By Troy Myers The U.S. Department of Justice (DOJ) is appealing the dismissal of a pair of criminal cases against...